BGB-A317
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for BGB-A317, covering 2021-11-17 to 2024-10-23. Get the full timeline:
Most recent: Clinical Trial Update: BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma [Phase 2]